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Piratoxin III (PrTX-III) is a phospholipase A2 (PLA2, E.C. 3.1.1.4,
phosphatide sn-2 acylhydrolase) isolated from Bothrops pirajai.
Crystals of PrTX-III were obtained using the vapour-diffusion
technique and X-ray diffraction data have been collected to 2.7 AÊ
resolution. The enzyme was crystallized in the space group C2 with
unit-cell parameters a = 60.88, b = 100.75, c = 48.19 AÊ ,  = 123.89. A
molecular-replacement solution of the structure has been found using
bothropstoxin I from the venom of B. jararacussu as a search model.
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1. Introduction
The genus Bothrops comprises several species
which are widely distributed in South and
North America. Among the bioactive proteins
from Bothrops venoms, phospholipases A2
appear as a major component. Phospholipases
A2 (PLA2, E.C. 3.1.1.4) are calcium-dependent
enzymes which are responsible for the cleavage
of the sn-2 ester bond of phospholipids
(Deenen & de Haas, 1963). They are found in
most animal tissues, mainly in the pancreatic
juices of mammals and the venoms of snakes
and insects. The PLA2 enzymes are believed to
participate in cellular functions and cell
signalling (Kudo et al., 1993), as well as in the
formation of several important metabolic
precursors (e.g. in¯ammatory response
mediators) derived from cleavage of the
phospholipids (Siraganian, 1988). These
enzymes are classi®ed into four groups,
according to their extracellular or intracellular
origin, primary structure and disul®de-bond
pattern (Heinrikson, 1990; Dennis, 1994).
Class II PLA2s constitute a large part of the
venom of many species of snake, such as
rattlesnakes and vipers (Mebs & Samejima,
1986). The enzymes belonging to this class can
be subdivided into two distinct groups,
according to enzymatic activity: the inactive
group and the active group (Maraganore et al.,
1984). The enzymatically inactive PLA2s (K-49
PLA2, PLA2-like myotoxins) are PLA2s which
exhibit low or no phospholipid cleavage
activity. This is thought to arise from a substi-
tution of the aspartate residue at position 49,
the side chain of which is important in the
binding of calcium ions (an essential cofactor),
by a lysine residue (Holland et al., 1990; Scott et
al., 1992; Arni et al., 1995). However, despite
the low or lack of enzymatic activity, K-49
PLA2s exhibits several different pharmaco-
logical activities, such as post-synaptic neuro-
toxicity, oedema formation (GutieÂ rrez &
Lomonte, 1995), myotoxicity (Lomonte et al.,
1994) and liposome and membrane disruption
(DõÂas et al., 1991; Ruf®ni et al., 1992). The
enzymatically active PLA2s (D-49 PLA2s)
hydrolyse the sn-2 ester bond of 1,2-diacyl-3-
sn-phosphoglycerides. The D-49 PLA2s require
calcium ion and are almost all at least 100 times
more active when the substrate is condensed in
micelles (Pieterson et al., 1974) or lamellar
aggregates such as monolayers, vesicles and
membranes (Slotboom et al., 1981).
In this work, we present the crystallization
and preliminary diffraction data of piratoxin
III (PrTX-III) myotoxin. PrTX-III is a D-49
PLA2 with moderate PLA2 activity, myotoxic
and anticoagulant activity. It was isolated from
B. pirajai snake venom (Toyama et al., 1998)
which was a kind gift from CEPIAC/CEPEC
(Ministry of Agriculture, Bahia, Brazil). The
enzymatically inactive K-49 PLA2 piratoxin II
(PrTX-II) from B. pirajai has previously been
crystallized in our group and is currently in the
process of structural re®nement (Lee et al.,
1998). Comparison of two (active and inactive)
phospholipases from the same organism will
provide us with more information on the
structural differences and shed light on the
activity of these proteins.
2. Protein puri®cation
PrTX-III was isolated and puri®ed from the
whole venom of B. pirajai by reverse-phase
and cation-exchange HPLC. 20 mg of whole
venom were dissolved in 250 ml of 0.1%(v/v)
tri¯uoroacetic acid. The resulting sample was
centrifuged and the supernatant was applied to
a 0.78  30 cm u-Bondapack C-18 column
(Waters 991 PDA system).
The puri®cation of the venom was
performed with a linear gradient of
0±66%(v/v) acetonitrile in 0.1%(v/v) tri-
¯uoroacetic acid at a ¯ow rate of 2.0 ml minÿ1
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and was monitored at 280 nm. The PrTX-III
fraction was lyophilized and dissolved in
0.05 M ammonium bicarbonate pH 7.4,
centrifuged and applied to a 0.39  7.8 cm
Protein-Pack SP 5PW cation-exchange
column, which had previously been equili-
brated with the same buffer. Elution of
PrTX-III was performed using a 0.05±1.0 M
ammonium bicarbonate (pH 7.4) linear
gradient. The chromatographic run was
performed at a ¯ow rate of 1.0 ml minÿ1 and
was monitored at 280 nm. The puri®ed
sample was lyophilized and used for crys-
tallization trials.
3. Crystallization and data collection
Preliminary screening of the crystallization
conditions was performed using a sparse-
matrix screen at 291 K (Crystal Screens I
and II, Hampton Research). Lyophilized
PrTX-III was initially dissolved to a
concentration of 10 mg mlÿ1 in water and
used in the screening procedure. Small
crystals were found in condition number 40
of the Crystal Screen I kit (20% 2-propanol,
20% PEG 4000, 0.1 M sodium citrate pH
5.6). A search for re®ned crystallization
conditions was then performed. New crystals
were grown at 291 K using the hanging-drop
vapour-diffusion technique by mixing equal
volumes (1 ml) of a protein solution
concentrated to 5 mg mlÿ1 with a reservoir
solution which contained 19% 2-propanol,
20% PEG 4000 and 0.1 M sodium citrate pH
5.5. Plate-like crystals measuring 0.1 0.1
0.02 mm appeared in 10±15 d.
X-ray diffraction data were collected at
the protein crystallography beamline (Poli-
karpov, Oliva et al., 1998; Polikarpov, Perles
et al., 1998) at the LaboratoÂ rio Nacional de
Luz SõÂncrotron (LNLS), Campinas, Brazil.
The images were recorded using a MAR 345
image plate and synchrotron radiation of
wavelength 1.38 AÊ . 110 oscillation images
were collected corresponding to a total
rotation of 132. The collected images were
processed and scaled with DENZO and
SCALEPACK (Otwinowski, 1993). The
crystals belong to the space group C2 with
unit-cell parameters a = 60.88, b = 100.75,
c = 48.19 AÊ ,  = 123.89. Data-set statistics
are given in Table 1.
Calculations using the Matthews coef®-
cient (Matthews, 1968) suggested the
presence of two molecules per asymmetric
unit (Vm = 2.84 AÊ
3 Daÿ1). The crystal
structure of PrTX-III was solved by the
molecular-replacement method using the
program AMoRe (Navaza, 1994). Several
molecular-replacement search models were
tested. The best solution was found with the
most homologous PLA2 available in the
main databases (all non-redundant
GenBank CDS translations, PDB, Swissprot,
PIR and PRF), bothropstoxin I from B.
jararacussu, which displayed 65% primary
sequence identity with PrTX-III. The atomic
coordinate ®le of bothropstoxin I was kindly
provided by the authors (Da Silva-Giotto et
al., 1998). The two most signi®cant rotation-
search solutions [correlation coef®cients
(CC) of 23.5 and 21.9%] were used for the
translation search using re¯ections in the
resolution range 10±2.7 AÊ . The best solution
of the translation search (CC = 43.1%;
R factor = 49.2%) was subjected to ten
cycles of rigid-body re®nement against all
data between 10 and 2.7 AÊ resolution (®tting
function of AMoRe). The ®tting yielded a
solution with a correlation coef®cient of
49.8% and an R factor of 48.1%. The crystal
packing was inspected using the program O
(Jones & Kjeldgaard, 1993) and did not
show any crystallographic or non-crystal-
lographic clashes. Initial re®nement steps
were performed using the maximum-like-
lihood method as implemented in the
program REFMAC (Murshudov et al., 1997).
At present, the R factor of the model is
31.3% and Rfree is 38.6%. Further model-
building and re®nement steps are under way.
We are very grateful to Dr Richard
Garratt for the atomic coordinates of
bothropstoxin I and to Dr Garib Murshudov
for his kind assistance in the initial re®ne-
ment. Financial support from CNPq,
CAPES and FAPESP is acknowledged.
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Table 1
Crystal data and data-collection statistics.
Crystal data
Space group C2
Unit-cell parameters (AÊ , ) a = 60.88, b = 100.75,
c = 48.19,  = 123.89
Data collection
Resolution (AÊ ) 2.70
Last resolution shell (AÊ ) 2.79±2.70





Last resolution shell (%) 26.4
Completeness (%) 84.5
Last resolution shell (%) 81.2
